Clinical trials
Recruiting Lymphoma, Non-Hodgkin trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 4 |
| Merck Sharp & Dohme LLC | 2 |
| Curis, Inc. | 1 |
| Grifols Therapeutics LLC | 1 |
| Kartos Therapeutics, Inc. | 1 |
| Loxo Oncology, Inc. | 1 |
| Miltenyi Biomedicine GmbH | 1 |
| Novartis Pharmaceuticals | 1 |
| Ryvu Therapeutics SA | 1 |
| Schrödinger, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 14 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Lymphoma, Follicular | 4 |
| Hematologic Neoplasms | 3 |
| Lymphoma, B-Cell | 3 |
| Waldenstrom Macroglobulinemia | 3 |
| Immune System Diseases | 2 |
| Immunoproliferative Disorders | 2 |
| Leukemia, B-Cell | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.